Source:http://linkedlifedata.com/resource/pubmed/id/19933179
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-26
|
pubmed:abstractText |
Purpose. To investigate whether female reproductive history and hormone replacement therapy (HRT) or birth control pills (BCPs) influence risk for age-related macular degeneration (AMD) and whether genetic factors interact with HRT to modulate AMD risk. Methods. Related and unrelated female participants (n = 799) were examined and data were analyzed with generalized estimating equations with adjustment for age and smoking. Individuals with AMD grades 1 to 2 were considered to be unaffected (n = 239) and those with grades 3 to 5 were considered affected (n = 560). Results. When comparing all cases with controls, significant inverse associations were observed for HRT (odds ratio [OR] = 0.65, 95% CI 0.48-0.90, P = 0.008) and BCPs (OR = 0.60, 95% CI 0.36-0.10, P = 0.048). When analyses were stratified by AMD severity (early versus geographic atrophy versus neovascular), the inverse association remained significant (HRT OR = 0.45, 95% CI 0.30-0.66, P < 0.0001; BCP OR = 0.55, 95% CI 0.32-0.96, P = 0.036) only when comparing neovascular AMD with the control. All pair-wise HRT-genotype and BCP-genotype interactions were examined, to determine whether HRT or BCP modifies the effect of established genetic risk factors. The strongest interactions were observed for HRT x ARMS2 coding SNP (R73H) rs10490923 (P = 0.007) and HRT x ARMS2 intronic SNP rs17623531 (P = 0.019). Conclusions. These findings provide the first evidence suggesting that ARMS2 interacts with HRT to modulate AMD risk and are consistent with previous reports demonstrating a protective relationship between exogenous estrogen use and neovascular AMD. These results highlight the genetic and environmental complexity of the etiologic architecture of AMD; however, further replication is necessary to validate them.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1552-5783
|
pubmed:author |
pubmed-author:AgarwalAnitaA,
pubmed-author:Ayala-HaedoJuanJ,
pubmed-author:EdwardsDigna R VelezDR,
pubmed-author:GallinsPaulP,
pubmed-author:HainesJonathan LJL,
pubmed-author:KovachJaclyn LJL,
pubmed-author:Pericak-VanceMargaretM,
pubmed-author:PolkMonicaM,
pubmed-author:PostelEric AEA,
pubmed-author:SchwartzStephen GSG,
pubmed-author:ScottWilliam KWK,
pubmed-author:SpencerKyleeK,
pubmed-author:WangGaofengG
|
pubmed:issnType |
Electronic
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1873-9
|
pubmed:dateRevised |
2010-10-4
|
pubmed:meshHeading |
pubmed-meshheading:19933179-Aged,
pubmed-meshheading:19933179-Contraceptives, Oral,
pubmed-meshheading:19933179-Estrogen Replacement Therapy,
pubmed-meshheading:19933179-Estrogens,
pubmed-meshheading:19933179-Female,
pubmed-meshheading:19933179-Genotype,
pubmed-meshheading:19933179-Humans,
pubmed-meshheading:19933179-Macular Degeneration,
pubmed-meshheading:19933179-Odds Ratio,
pubmed-meshheading:19933179-Polymorphism, Single Nucleotide,
pubmed-meshheading:19933179-Proteins,
pubmed-meshheading:19933179-Questionnaires,
pubmed-meshheading:19933179-Reproductive History
|
pubmed:year |
2010
|
pubmed:articleTitle |
Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms.
|
pubmed:affiliation |
Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|